Shiraz University of Medical Sciences
🇮🇷Iran
- Country
- 🇮🇷Iran
- Ownership
- Private
- Established
- 1946-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.gsia.sums.ac.ir
Clinical Trials
1.5k
Active:1
Completed:791
Trial Phases
6 Phases
Early Phase 1:18
Phase 1:48
Phase 2:287
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1507 trials with phase data)• Click on a phase to view related trials
Not Applicable
758 (50.3%)Phase 3
367 (24.4%)Phase 2
287 (19.0%)Phase 1
48 (3.2%)Phase 4
29 (1.9%)Early Phase 1
18 (1.2%)CTFFR and Prediction of Non-Significant CAD Lesions
Not Applicable
Recruiting
- Conditions
- Chronic Coronary Syndrome
- First Posted Date
- 2025-05-19
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Shiraz University of Medical Sciences
- Target Recruit Count
- 250
- Registration Number
- NCT06979427
- Locations
- 🇮🇷
Professor Kojuri Cardiology Clinic, Shiraz, Fars, Iran, Islamic Republic of
Effect of Probiotic Supplement on Improvement of Depressive Symptoms in Patients With Substance-Induced Depressive Disorder
Phase 1
Completed
- Conditions
- Depressive DisorderDepressive Disorder, Major Depressive Disorder
- Interventions
- Drug: The probiotic supplement (Moodamin capsuls)Drug: Placebo
- First Posted Date
- 2025-01-24
- Last Posted Date
- 2025-06-13
- Lead Sponsor
- Shiraz University of Medical Sciences
- Target Recruit Count
- 40
- Registration Number
- NCT06790823
- Locations
- 🇮🇷
Shiraz University of Medical Sciences, Shiraz, Iran, Shiraz, Fars, Iran, Islamic Republic of
Ticagrelore Alone Post PCI
Phase 4
Recruiting
- Conditions
- Coronary Artery Disease
- Interventions
- First Posted Date
- 2024-07-19
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Shiraz University of Medical Sciences
- Target Recruit Count
- 5400
- Registration Number
- NCT06509893
- Locations
- 🇮🇷
Cardiology Ward Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of
🇮🇷professor Kojuroi cardiology clinic, Shiraz, Iran, Islamic Republic of
Valsartan and Amlodipine in Blood Pressure Management: Fixed-Dose vs. Free Drug Therapy
Phase 4
Completed
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Shiraz University of Medical Sciences
- Target Recruit Count
- 114
- Registration Number
- NCT06487949
- Locations
- 🇮🇷
Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of
MACE in Different Drug-Eluting Stents
Completed
- Conditions
- Coronary Artery DiseaseStent Restenosis
- First Posted Date
- 2024-06-24
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- Shiraz University of Medical Sciences
- Target Recruit Count
- 4159
- Registration Number
- NCT06470529
- Locations
- 🇮🇷
Shiraz University of Medical Sciences, Shiraz, Fars, Iran, Islamic Republic of
- Prev
- 1
- 2
- 3
- 4
- 5
- 26
- Next
News
No news found